{
  "docId": "019dd923-622c-750b-8b96-fcb164354e3e",
  "docSlug": "86ed72671dc5",
  "documentTitle": "PeptiDream, Inc. (4587 JP)",
  "authorId": "51_Muddy_Waters",
  "authorName": "Carson C. Block",
  "documentKindSlug": "research-note",
  "documentKindLabel": "Research note",
  "sourceTypeSlug": "short_seller",
  "sourceTypeLabel": "Short seller",
  "presentationDate": "2019-11-07 00:00:00",
  "orientation": "portrait",
  "aspectRatio": 0.77272725,
  "pageNumber": 5,
  "pageCount": 22,
  "prevPage": 4,
  "nextPage": 6,
  "slideType": "preempt_rebuttal",
  "function": "expose_gap",
  "density": "balanced",
  "nDataPoints": 18,
  "notes": "The slide argues that technology does not equal a viable business, citing a lack of clinical candidates from long-standing partnerships.",
  "elementsJson": [
    "paragraph",
    "data_table",
    "footnote"
  ],
  "metadataConfidence": 1,
  "imagePath": null,
  "slideHref": "/slides/019dd923-622c-750b-8b96-fcb164354e3e/5",
  "deckHref": "/decks/019dd923-622c-750b-8b96-fcb164354e3e",
  "deckJsonHref": "/decks/019dd923-622c-750b-8b96-fcb164354e3e.json",
  "deckAnchorHref": "/decks/019dd923-622c-750b-8b96-fcb164354e3e#slide-5",
  "components": [
    {
      "bbox": null,
      "kind": "callout",
      "text": "Only one of the 14 partnerships that are at least four years old has led to a drug in clinical trials.",
      "attrs": null,
      "subkind": null,
      "toolName": "Visual emphasis",
      "toolSlug": "visual-emphasis",
      "confidence": null,
      "componentId": "019dd953-14dd-72ca-b97a-56b642d01e8b",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.06,
        "w": 0.78,
        "x": 0.11,
        "y": 0.81
      },
      "kind": "paragraph",
      "text": "We speculate that partners do not formally terminate partnerships for reasons including a desire to save face for PeptiDream, and partners' senior management not focusing on the state of the PeptiDream partnership due to its small size.",
      "attrs": null,
      "subkind": "paragraph",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "308ef7f8-9121-4428-8a5c-430a5d894c14",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.08,
        "w": 0.78,
        "x": 0.11,
        "y": 0.09
      },
      "kind": "paragraph",
      "text": "since March 31, 2017. This implies that half of the partnerships currently have little to no activity. Our external researchers' work supports the view that a significant number of partnerships lack activity.",
      "attrs": null,
      "subkind": "paragraph",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "309018a1-33d2-4c04-ba9d-351933c58cd5",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.15,
        "w": 0.78,
        "x": 0.11,
        "y": 0.62
      },
      "kind": "paragraph",
      "text": "Technology does not necessarily equal a viable business. Peptide drug discovery experts with whom we have spoken acknowledged that PeptiDream's technology finds “hits” against selected targets, but they appear not to translate into development of viable drug candidate molecules.",
      "attrs": null,
      "subkind": "paragraph",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "cfd31b7d-386b-4dc6-95ca-1d1eece5385c",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.02,
        "w": 0.35,
        "x": 0.11,
        "y": 0.89
      },
      "kind": "source-note",
      "text": "11 Source: PeptiDream's website and press releases.",
      "attrs": null,
      "subkind": null,
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "f21eec64-74a1-4656-b71b-ade1bec23d1d",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.38,
        "w": 0.78,
        "x": 0.11,
        "y": 0.22
      },
      "kind": "table",
      "text": "Company, Signed, Activity within current and previous financial years (July 2017 to date)",
      "attrs": null,
      "subkind": "data",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "012f764d-d9f3-450a-88f3-c8ad4533ba66",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [
    {
      "name": "Table data",
      "slug": "table-data",
      "agent": null,
      "layer": "slide",
      "matchId": "4db24442-af04-4598-8e6e-a61271060bee",
      "evidence": "The slide presents a table with data on PeptiDream's partnerships, including signing dates and activity levels.",
      "confidence": 0.7
    }
  ],
  "frameworks": [
    {
      "name": "evidence-matrix",
      "slug": null,
      "matchId": "bb3fa8e8-4e68-42b8-9868-59dc337623fc",
      "evidence": "The slide uses a table of partnership data to support a qualitative argument about business viability.",
      "confidence": 0.8
    }
  ],
  "arcBeats": [
    {
      "to": 6,
      "from": 4,
      "beatId": "e323a058-f79c-4393-8cf9-72558831e366",
      "arcName": "Overcoming the Monster",
      "arcSlug": "overcoming-monster",
      "beatName": "The Monster",
      "beatSlug": "overcoming-monster-the-monster",
      "evidence": "Critique of PeptiDream's partnerships",
      "position": 0,
      "confidence": 0.8,
      "parentBeatName": "Hook",
      "parentBeatSlug": "hook"
    }
  ],
  "loops": [],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}